Age (yr) (mean) | 55.7 ± 13.0 | 56.8 ± 9.2 | 56.0 ± 12.6 | 56.2 ± 11.6 |
Age range (yr) | 23–79 | 31–72 | 25–77 | 23–79 |
Male (%) | 40 (66%) | 38 (55%) | 36 (50%) | 114 (56%) |
Median survival (days ± IQR)a | 628 (±c | 588 (± 356) | 752 (± 1023) | 553 (± 507) |
Gross total resection (yes/no) (% in yes)a | 28/33 (46%) | 27/42 (39%) | 41/31 (57%) | 96/106 (48%) |
Methylation (M1/U2/X3)b | 24/36/1 | 24/45/0 | 26/35/11 | 74/116/12 |
IDH1 mutant/wild type | 7/54 | 4/65 | 3/69 | 14/188 |
nCET (yes/no) (% in yes) | 20/41 (32%) | 22/47 (35%) | 21/51 (33%) | 63/139 (32%) |
Edema (no, mild/moderate, severe) (% in no or mild) | 28/33 (46%) | 22/47 (32%) | 23/49 (32%) | 73/129 (36%) |